REGN - RBC ups Regeneron to outperform; cites Eylea patent win Dupi sales
2024-01-12 14:11:03 ET
More on Regeneron Pharmaceuticals
- Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript)
- Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade)
- Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript)
- Regeneron eyes Wegovy combo to improve quality of weight loss
- Regeneron to post over $1.3B U.S. Eylea sales in Q4
For further details see:
RBC ups Regeneron to outperform; cites Eylea patent win, Dupi sales